Investing Profile

Igor DaCruz

InvestorVC
Managing Director, Life Sciences at Runway Growth Capital
Photo of Igor DaCruz, Managing Director at Runway Growth Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Runway Growth Capital Managing Director
$10.0M - $50.0M
$25.0M
4
CompanyStageDateRound SizeTotal Raised
Neurolens
Series UnknownDec 2023$45M
$45M
SetPoint Medical
Debt FinancingJan 2023$65M
$310M
Co-investors: Zack Scott (Norwest Venture Partners), Juan-Pablo Mas (Action Potential Venture Capital), Hank Plain (Morgenthaler Ventures), William Dai (ShangBay Capital)
Revelle Aesthetics
Debt FinancingApr 2022$25M
$25M
Mustang Bio
Post Ipo DebtMar 2022$75M
$75M